Bernd Kruss
6Patents
3h-index
17Co-inventors
54Inventor score
Filing activity: Aug 21, 1987 → Oct 19, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5858410A | Pharmaceutical nanosuspensions for medicament administration as systems with increased saturation solubility and rate of solution | Human Necessities | 160 | Expired |
| US6982256B2 | Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administration | Human Necessities | 11 | Expired |
| US4824674A | Stable alpha-interferon dosage forms | Human Necessities | 11 | Expired |
| US9993557B2 | Highly concentrated stable meloxicam solutions | Human Necessities | 1 | Expired |
| US9956288B2 | Highly concentrated stable meloxicam solutions | Human Necessities | 0 | Active |
| US6828311B2 | Formulation for the parenteral application of a sodium channel blocker | Performing Operations; Transporting | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.